TGA recalls two more Australian sunscreens over suspect SPF claims

Two more Aussie sunscreens have been recalled for failing to meet their advertised sun protection factor (SPF) claims.

KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...